FDA 483 - Healthplus LLC - August 07, 2025

An FDA inspection of Healthplus LLC in Asheville, NC, from August 4-7, 2025, identified one significant observation. The firm failed to adequately validate the design of a Class II medical device using initial production units, lacking sufficient records to confirm the manufacturing and acceptance of devices used in validation activities. This indicates a deficiency in their design control processes.